Citigroup Inc. increased its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Get Rating) by 15.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 35,533 shares of the business services provider's stock after acquiring an additional 4,759 shares during the period. Citigroup Inc. owned approximately 0.07% of Exponent worth $3,521,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. American Century Companies Inc. raised its position in shares of Exponent by 17.2% during the 1st quarter. American Century Companies Inc. now owns 5,865 shares of the business services provider's stock valued at $634,000 after acquiring an additional 859 shares in the last quarter. MetLife Investment Management LLC boosted its stake in Exponent by 55.0% during the first quarter. MetLife Investment Management LLC now owns 27,848 shares of the business services provider's stock valued at $3,009,000 after buying an additional 9,879 shares in the last quarter. Rhumbline Advisers boosted its stake in Exponent by 4.3% during the first quarter. Rhumbline Advisers now owns 151,520 shares of the business services provider's stock valued at $16,372,000 after buying an additional 6,235 shares in the last quarter. Raymond James Trust N.A. lifted its holdings in shares of Exponent by 12.5% during the first quarter. Raymond James Trust N.A. now owns 6,573 shares of the business services provider's stock valued at $710,000 after purchasing an additional 728 shares during the last quarter. Finally, Sei Investments Co. lifted its holdings in shares of Exponent by 21.2% during the first quarter. Sei Investments Co. now owns 69,519 shares of the business services provider's stock valued at $7,545,000 after purchasing an additional 12,174 shares during the last quarter. 91.32% of the stock is owned by institutional investors and hedge funds.
Exponent Trading Up 1.7 %
Shares of EXPO stock opened at $90.24 on Tuesday. The company has a market capitalization of $4.58 billion, a P/E ratio of 46.04 and a beta of 0.64. Exponent, Inc. has a 12 month low of $80.97 and a 12 month high of $112.75. The stock has a 50 day moving average of $94.60 and a two-hundred day moving average of $99.50.
Exponent (NASDAQ:EXPO - Get Rating) last released its quarterly earnings results on Thursday, April 27th. The business services provider reported $0.56 earnings per share for the quarter, meeting analysts' consensus estimates of $0.56. The firm had revenue of $140.30 million during the quarter, compared to analysts' expectations of $127.17 million. Exponent had a return on equity of 30.86% and a net margin of 19.39%. The business's revenue was up 19.0% on a year-over-year basis. During the same period last year, the firm posted $0.56 EPS. Sell-side analysts predict that Exponent, Inc. will post 2.1 earnings per share for the current fiscal year.
Exponent Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 23rd. Shareholders of record on Friday, June 9th will be issued a dividend of $0.26 per share. The ex-dividend date of this dividend is Thursday, June 8th. This represents a $1.04 annualized dividend and a yield of 1.15%. Exponent's dividend payout ratio is presently 53.06%.
Insiders Place Their Bets
In related news, VP Harri Kytomaa sold 350 shares of the company's stock in a transaction dated Friday, February 24th. The stock was sold at an average price of $103.24, for a total transaction of $36,134.00. Following the sale, the vice president now owns 12,064 shares in the company, valued at $1,245,487.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, VP Bradley A. James sold 1,500 shares of the business's stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $89.36, for a total value of $134,040.00. Following the completion of the sale, the vice president now directly owns 7,584 shares in the company, valued at $677,706.24. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Harri Kytomaa sold 350 shares of the company's stock in a transaction on Friday, February 24th. The stock was sold at an average price of $103.24, for a total value of $36,134.00. Following the sale, the vice president now owns 12,064 shares of the company's stock, valued at $1,245,487.36. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 3,238 shares of company stock worth $290,361. Corporate insiders own 2.00% of the company's stock.
Analysts Set New Price Targets
Several brokerages recently issued reports on EXPO. TheStreet downgraded Exponent from a "b" rating to a "c+" rating in a research note on Wednesday, May 17th. StockNews.com began coverage on Exponent in a research report on Thursday, May 18th. They issued a "hold" rating on the stock.
Exponent, Inc is an engineering and scientific consulting company, which engages in the provision of engineering, scientific, environmental, and health consulting services. It operates through the Engineering and Other Scientific, and Environmental and Health segments. The Engineering and Other Scientific segment includes technical consulting in different practices primarily in engineering.
- Get a free copy of the StockNews.com research report on Exponent (EXPO)
- monday.com Surges on Price and Volume after Blowout Results
- Can Ryanair Stock Fly Above Resistance Levels, What Earnings Show
- All Aboard! The Sell-Side Has Railroads In Reversal
- Is There Value Left in Lyft Stock?
- Everything About ZIM Integrated Screams Undervaluation
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to email@example.com.
Should you invest $1,000 in Exponent right now?
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Beginners Guide To Retirement Stocks
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report